RIPERTAMAB

Clinical trials for RIPERTAMAB explained in plain language.

Never miss a new study

Get alerted when new RIPERTAMAB trials appear

Sign up with your email to follow new studies for RIPERTAMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for kids with kidney disease: fewer relapses with ripertamab?

Disease control Not yet recruiting

This study tests whether one or two doses of ripertamab can help children aged 16 and older with nephrotic syndrome who relapse often or depend on steroids. The goal is to see which dose keeps them relapse-free longer and reduces steroid use. About 312 children will take part, an…

Matched conditions: RIPERTAMAB

Phase: NA • Sponsor: Mao Jianhua • Aim: Disease control

Last updated May 26, 2026 11:53 UTC

RIPERTAMAB

Get alerted when new RIPERTAMAB trials appear

New hope for kids with kidney disease: fewer relapses with ripertamab?